Compare ISTR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISTR | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.5M | 419.3M |
| IPO Year | 2014 | 2008 |
| Metric | ISTR | CYRX |
|---|---|---|
| Price | $28.54 | $13.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $31.50 | $13.31 |
| AVG Volume (30 Days) | 126.1K | ★ 662.7K |
| Earning Date | 04-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | 4.41 | ★ 156.22 |
| EPS | ★ 0.77 | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $66.56 | $11.06 |
| Revenue Next Year | $5.18 | $8.45 |
| P/E Ratio | $37.13 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.89 | $5.31 |
| 52 Week High | $30.49 | $14.36 |
| Indicator | ISTR | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 71.94 |
| Support Level | $26.18 | $7.98 |
| Resistance Level | $28.84 | N/A |
| Average True Range (ATR) | 0.50 | 0.75 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 72.19 | 89.05 |
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.